1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Tumor Lysis Syndrome Global Clinical Trials Review, H1, 2014

Tumor Lysis Syndrome Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Tumor Lysis Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Tumor Lysis Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tumor Lysis Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tumor Lysis Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Tumor Lysis Syndrome Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Tumor Lysis Syndrome 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Tumor Lysis Syndrome 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Tumor Lysis Syndrome Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Sanofi 26
Clinical Trial Overview of Sanofi 26
Takeda Pharmaceutical Company Limited 27
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 27
A. Menarini Industrie Farmaceutiche Riunite Srl 28
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 28
Clinical Trial Overview of Top Institutes / Government 29
The University of Texas M. D. Anderson Cancer Center 29
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 29
University of Fukui 30
Clinical Trial Overview of University of Fukui 30
Five Key Clinical Profiles 31
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 74

List of Tables
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Region, 2014* 6
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Tumor Lysis Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Tumor Lysis Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Tumor Lysis Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Tumor Lysis Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 13
Tumor Lysis Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tumor Lysis Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 16
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Tumor Lysis Syndrome Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Tumor Lysis Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Tumor Lysis Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 26
Tumor Lysis Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 27
Tumor Lysis Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014* 28
Tumor Lysis Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 29
Tumor Lysis Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Fukui, 2014* 30

List of Figures
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Tumor Lysis Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Tumor Lysis Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 13
Tumor Lysis Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Tumor Lysis Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Tumor Lysis Syndrome to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 16
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Tumor Lysis Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Tumor Lysis Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Tumor Lysis Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 73

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.